THE ESSENTIAL
• Organizations involved in medical research have denounced what they believe to be a “wild” therapeutic trial with hydroxychloroquine at the IHU Méditerranée Infection in Marseille. read our article
• The microbiologist Didier Raoult was then the director and co-author of the study pre-published in April on the controversial clinical trial. listen to our podcast
• Professor Raoult is the guest of BFMTV this Tuesday at 9 am
Didier Raoult will be on BFMTV at 9 am
Professor Raoult will speak about these events on BFMTV at 9 am Follow his speech on BFMTV and BFMTV.com.
Hydroxychloroquine administered until the end of 2021
For this clinical trial, doctors at the IHU in Marseille administered, as the standard treatment against Covid-19, a combination of hydroxychloroquine (HCQ) and azithromycin (AZ).
Mathieu Molimard, professor of pharmacology at the Bordeaux University Hospital and signatory to the forum, also denounced on BFMTV the administration of the HCQ-AZ combination “long after the formal demonstration of the ineffectiveness of this treatment, provided during the summer of 2020.” .
A forum addressed to Didier Raoult
In a column published Sunday in The worldorganizations involved in medical research denounce the method used by scientists at the IHU Méditerranée Infection in Marseille to carry out a “wild” therapeutic trial with hydroxychloroquine.
Carried out between 2020 and 2021, it gave rise to a study pre-published in April, co-authored by Didier Raoult. We explain this controversy in this article.
Hello, everyone
Hello everyone and welcome to this live.
It will be dedicated to the intervention of the microbiologist Didier Raoult on BFMTV at 9 am, a few days after the publication of a column accusing him of having carried out, with other scientists, a “wild” therapeutic trial in Marseille.
main articles
Source: BFM TV
